To evaluate the efficacy, safety and tolerability of vibegron for the treatment of antimuscarinic‐resistant neurogenic bladder dysfunction in patients with spina bifida. Click to show full abstract
To evaluate the efficacy, safety and tolerability of vibegron for the treatment of antimuscarinic‐resistant neurogenic bladder dysfunction in patients with spina bifida.
               
Click one of the above tabs to view related content.